* price as on 19 Nov 2024
Financial
Mar-24A Mar-25F Mar-26F Mar-27F
Revenue (Rsm) 5,198 6,226 8,110 10,934
Operating EBITDA (Rsm) 2,216 2,708 3,405 4,521
Net Profit (Rsm) 1,817 2,224 2,717 3,555
Core EPS (Rs) 32.4 39.7 48.5 63.5
Core EPS Growth 46.5% 22.4% 22.2% 30.8%
FD Core P/E (x) 70.62 57.70 47.22 36.09
DPS (Rs) 4.5 5.6 6.9 9.0
Dividend Yield 0.20% 0.25% 0.30% 0.39%
EV/EBITDA (x) 56.13 45.72 36.08 26.70
P/FCFE (x) (150.55) 396.90 405.94 124.77
Net Gearing (29.7%) (29.8%) (31.4%) (36.9%)
P/BV (x) 9.69 8.47 7.34 6.25
ROE 14.6% 15.7% 16.7% 18.7%
% Change In Core EPS Estimates
InCred Research/Consensus EPS (x)
(Rs mn) Mar-24A Mar-25F Mar-26F Mar-27F
Total Net Revenues 5,198 6,226 8,110 10,934
Gross Profit 3,547 4,350 5,515 7,370
Operating EBITDA 2,216 2,708 3,405 4,521
Depreciation And Amortisation (161) (144) (212) (251)
Operating EBIT 2,055 2,564 3,193 4,270
Financial Income/(Expense) (93) (119) (138) (186)
Pretax Income/(Loss) from Assoc.
Non-Operating Income/(Expense) 460 514 568 656
Profit Before Tax (pre-EI) 2,422 2,959 3,623 4,740
Exceptional Items
Pre-tax Profit 2,422 2,959 3,623 4,740
Taxation (605) (735) (906) (1,185)
Exceptional Income - post-tax
Profit After Tax 1,817 2,224 2,717 3,555
Minority Interests
Preferred Dividends
FX Gain/(Loss) - post tax
Other Adjustments - post-tax
Net Profit 1,817 2,224 2,717 3,555
Recurring Net Profit 1,817 2,224 2,717 3,555
Fully Diluted Recurring Net Profit 1,817 2,224 2,717 3,555
(Rs mn) Mar-24A Mar-25F Mar-26F Mar-27F
EBITDA 2,216 2,708 3,405 4,521
Cash Flow from Invt. & Assoc.
Change In Working Capital (213) (521) 239 141
(Incr)/Decr in Total Provisions
Other Non-Cash (Income)/Expense 164
Other Operating Cashflow (143)
Net Interest (Paid)/Received
Tax Paid (631) (735) (906) (1,185)
Cashflow From Operations 1,394 1,451 2,738 3,477
Capex (872) (900) (769) (414)
Disposals Of FAs/subsidiaries
Acq. Of Subsidiaries/investments
Other Investing Cashflow (1,367) (228) (1,653) (2,035)
Cash Flow From Investing (2,239) (1,128) (2,422) (2,449)
Debt Raised/(repaid) (7)
Proceeds From Issue Of Shares
Shares Repurchased
Dividends Paid (252) (316) (386) (505)
Preferred Dividends
Other Financing Cashflow (162) (113) (91) (115)
Cash Flow From Financing (421) (429) (477) (620)
Total Cash Generated (1,266) (106) (160) 408
Free Cashflow To Equity (852) 323 316 1,028
Free Cashflow To Firm (845) 323 316 1,028
(Rs mn) Mar-24A Mar-25F Mar-26F Mar-27F
Total Cash And Equivalents 3,927 4,511 5,481 7,584
Total Debtors 3,988 4,605 5,333 6,590
Inventories 2,668 2,900 3,333 4,194
Total Other Current Assets 804 921 1,111 1,198
Total Current Assets 11,387 12,937 15,258 19,566
Fixed Assets 1,983 2,725 3,282 3,446
Total Investments 2,622 2,490 3,244 4,374
Intangible Assets
Total Other Non-Current Assets 926 1,109 1,445 1,312
Total Non-current Assets 5,531 6,324 7,971 9,131
Short-term Debt
Current Portion of Long-Term Debt
Total Creditors 501 600 800 1,198
Other Current Liabilities 2,956 3,292 4,666 6,590
Total Current Liabilities 3,457 3,892 5,466 7,789
Total Long-term Debt
Hybrid Debt - Debt Component
Total Other Non-Current Liabilities 150 156 203 273
Total Non-current Liabilities 150 156 203 273
Total Provisions 69 77 94 118
Total Liabilities 3,676 4,125 5,763 8,181
Shareholders Equity 13,242 15,150 17,482 20,532
Minority Interests
Total Equity 13,242 15,150 17,482 20,532
Mar-24A Mar-25F Mar-26F Mar-27F
Revenue Growth 14.6% 19.8% 30.3% 34.8%
Operating EBITDA Growth 29.0% 22.2% 25.7% 32.8%
Operating EBITDA Margin 42.6% 43.5% 42.0% 41.3%
Net Cash Per Share (Rs) 70.12 80.55 97.88 135.42
BVPS (Rs) 236.47 270.54 312.17 366.64
Gross Interest Cover 22.02 21.60 23.16 22.97
Effective Tax Rate 25.0% 24.8% 25.0% 25.0%
Net Dividend Payout Ratio 13.9% 14.2% 14.2% 14.2%
Accounts Receivables Days 274.30 251.90 223.63 199.01
Inventory Days 508.14 541.89 438.27 385.37
Accounts Payables Days 104.63 107.19 98.45 102.31
ROIC (%) 29.0% 37.1% 38.2% 47.2%
ROCE (%) 16.5% 18.0% 19.5% 22.4%
Return On Average Assets 12.2% 13.0% 13.4% 14.4%

Analyst(s)

Arafat SAIYED

(91) 22 4161 1542 arafat.saiyed@incredresearch.com

Anirvan DIVAKERA

(91) 02241611548 anirvan.divakera@incredresearch.com